A groundbreaking report confirmed that high expression of CAF-specific VEGFA, PGE2S, COX2, EGFR, CCL2, and NANOG was considered as the culprit of CDDP resistance development in head and neck squamous cell carcinoma (HNSCC) [68]. This evidence concerns the gene CCL2 and head and neck squamous cell carcinoma.